1584674
Last Update Posted: 2013-05-17
Recruiting has ended
All Genders accepted | 16 Years-30 Years |
98 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne
The purpose of this study is to evaluate the safety and efficacy of the KLOX Biophotonic System in patients with moderate to severe facial acne vulgaris using a split-face design (treated hemiface vs untreated hemiface).
Eligibility
Relevant conditions:
Acne Vulgaris
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov